α-Lipoic acid treatment prevents cystine urolithiasis in a mouse model of cystinuria

被引:48
|
作者
Zee, Tiffany [1 ,2 ]
Bose, Neelanjan [1 ,2 ]
Zee, Jarcy [3 ]
Beck, Jennifer N. [1 ,2 ]
Yang, See [2 ]
Parihar, Jaspreet [4 ]
Yang, Min [5 ,6 ]
Damodar, Sruthi [2 ]
Hall, David [2 ]
O'Leary, Monique N. [2 ]
Ramanathan, Arvind [2 ]
Gerona, Roy R. [7 ]
Killilea, David W. [1 ,8 ]
Chi, Thomas [1 ]
Tischfield, Jay [5 ,6 ]
Sahota, Amrik [5 ,6 ]
Kahn, Arnold [2 ]
Stoller, Marshall L. [1 ]
Kapahi, Pankaj [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94117 USA
[2] Buck Inst Res Aging, Novato, CA 94945 USA
[3] Arbor Res Collaborat Hlth, Ann Arbor, MI USA
[4] Rutgers State Univ, Robert Wood Johnson Med Sch, Div Urol, New Brunswick, NJ USA
[5] Rutgers State Univ, Dept Genet, Piscataway, NJ USA
[6] Rutgers State Univ, Human Genet Inst New Jersey, Piscataway, NJ USA
[7] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA
[8] Childrens Hosp, Oakland Res Inst, Nutr & Metab Ctr, 747 52nd St, Oakland, CA 94609 USA
关键词
KIDNEY-STONES; GLUTATHIONE; DISEASE;
D O I
10.1038/nm.4280
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cystinuria is an incompletely dominant disorder characterized by defective urinary cystine reabsorption that results in the formation of cystine-based urinary stones. Current treatment options are limited in their effectiveness at preventing stone recurrence and are often poorly tolerated. We report that the nutritional supplement alpha-lipoic acid inhibits cystine stone formation in the Slc3a1(-/-) mouse model of cystinuria by increasing the solubility of urinary cystine. These findings identify a novel therapeutic strategy for the clinical treatment of cystinuria.
引用
收藏
页码:288 / 290
页数:3
相关论文
共 50 条
  • [41] REACTION OF PEROXYACETYL NITRATE WITH CYSTEINE, CYSTINE, METHIONINE, LIPOIC ACID, PAPAIN, AND LYSOZYME
    LEH, F
    MUDD, JB
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1974, 161 (01) : 216 - 221
  • [42] Lipoic acid prevents steroid-induced osteonecrosis in rabbits
    Lu, Bang-Bao
    Li, Kang-Hua
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (06) : 1679 - 1683
  • [43] Lipoic acid prevents steroid-induced osteonecrosis in rabbits
    Bang-Bao Lu
    Kang-Hua Li
    Rheumatology International, 2012, 32 : 1679 - 1683
  • [44] Lipoic Acid Prevents the Changes of Intracellular Lipid Partitioning by Free Fatty Acid
    Kim, Dong Chan
    Jun, Dae Won
    Jang, Eun Chul
    Kim, Sang Heum
    Kim, Eun Kyung
    Lee, Sang Pyo
    Lee, Kang Nyeong
    Lee, Hang Lak
    Lee, Oh Young
    Yoon, Byung Chul
    Choi, Ho Soon
    GUT AND LIVER, 2013, 7 (02) : 221 - 227
  • [45] TREATMENT OF CYSTINE UROLITHIASIS BY A COMBINATION OF EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY AND CHEMOLYSIS
    AHLSTRAND, C
    TISELIUS, HG
    JOURNAL OF STONE DISEASE, 1993, 5 (01): : 32 - 38
  • [46] Clodronate Treatment Prevents Vaginal Hypersensitivity in a Mouse Model of Vestibulodynia
    Castro, Joel
    Harrington, Andrea M.
    Chegini, Fariba
    Matusica, Dusan
    Spencer, Nick J.
    Brierley, Stuart M.
    Haberberger, Rainer V.
    Barry, Christine M.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 11
  • [47] α-Lipoic acid treatment prevents the diabetes-induced attenuation of the afferent limb of the baroreceptor reflex in rats
    Gouty, S
    Regalia, J
    Cai, F
    Helke, CJ
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2003, 108 (1-2): : 32 - 44
  • [48] Lipoic acid reduces inflammation in a mouse focal cortical experimental autoimmune encephalomyelitis model
    Chaudhary, Priya
    Marracci, Gail
    Galipeau, Danielle
    Pocius, Edvinas
    Morris, Brooke
    Bourdette, Dennis
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 289 : 68 - 74
  • [49] THE DIURNAL RENAL EXCRETION OF CYSTINE AND ITS SIGNIFICANCE FOR TREATMENT WITH CHELATING-AGENTS IN PATIENTS WITH CYSTINURIA
    DEWOLF, JTM
    GEUS, WP
    VANDENENDE, A
    HOENDERDOSBLOM, P
    VANEPS, LWS
    KIDNEY INTERNATIONAL, 1983, 23 (01) : 120 - 120
  • [50] THE DIURNAL RENAL EXCRETION OF CYSTINE AND ITS SIGNIFICANCE FOR TREATMENT WITH CHELATING-AGENTS IN PATIENTS WITH CYSTINURIA
    VANDENENDE, A
    VANZANTEN, AP
    BACKER, ET
    DEWOLF, JTM
    GEUS, WP
    VANEPS, LWS
    UROLOGICAL RESEARCH, 1984, 12 (01): : 34 - 34